CRBU Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03

Harga $1.22

Kapitalisasi Pasar (MRQ) $129M

P/E (TTM) -1.1

EPS (TTM) $-1.08

Pendapatan (TTM) $10M

ROE (TTM) -78.3%

Rentang 52M $1–$4

CRBU Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04

rentang

batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06

Pendapatan$11M

2019-12-31 → 2025-12-31

EPS$-1.59

2021-12-31 → 2025-12-31

Arus Kas Bebas$-112M

2021-12-31 → 2025-12-31

Margin bersih-1030.4%

2021-12-31 → 2025-12-31

Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik	CRBU	rata-rata 5T	Median Rekan	Kesimpulan
P/E (TTM)	-1.1rata-rata 5T ≈-3.4	≈-3.4	·	·
P/S (TTM)	12.9rata-rata 5T ≈33.1	≈33.1	40.4	Kurang nilai
P/B (MRQ)	1.3rata-rata 5T ≈1.4	≈1.4	2.4	Kurang nilai
Harga / FCF (TTM)	-1.4rata-rata 5T ≈-7.5	≈-7.5	·	·
Harga / Arus Kas (TTM)	-1.4rata-rata 5T ≈-8.0	≈-8.0	·	·
Price / Tangible Book (Harga / Nilai Buku Berwujud)	1.0rata-rata 5T ≈1.4	≈1.4	·	·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik	CRBU	rata-rata 5T	Median Rekan	Kesimpulan
Margin Operasi (TTM)	-1090.9%rata-rata 5T ≈-959.8%	≈-959.8%	-3077.6%	Tingkat teratas
Margin EBITDA (TTM)	-1065.1%rata-rata 5T ≈-939.0%	≈-939.0%	-3077.6%	Tingkat teratas
Pretax Margin (Margin Sebelum Pajak)	-1332.3%rata-rata 5T ≈-906.2%	≈-906.2%	-3779.8%	Tingkat teratas
Margin Laba Bersih (TTM)	-1030.4%rata-rata 5T ≈-906.1%	≈-906.1%	-3650.4%	Tingkat teratas
ROA (TTM)	-56.9%rata-rata 5T ≈-35.7%	≈-35.7%	-66.8%	Sejajar
ROE (TTM)	-78.3%rata-rata 5T ≈-46.8%	≈-46.8%	-108.3%	Sejajar
ROIC	-121.0%rata-rata 5T ≈-54.2%	≈-54.2%	-98.3%	Di bawah rata-rata

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik	Tren 5 Tahun	CRBU	rata-rata 5T	Median Rekan	Kesimpulan
Rasio Lancar (MRQ)		6.5rata-rata 5T ≈9.8	≈9.8	4.2	Likuiditas kuat
Quick Ratio (Rasio Cepat)		0.5rata-rata 5T ≈2.9	≈2.9	1.7	Likuiditas rendah

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik	CRBU	rata-rata 5T	Median Rekan	Kesimpulan
Revenue YoY (Pendapatan YoY)	11.7%rata-rata 5T ≈22.3%	≈22.3%	·	·
Revenue CAGR 3Y (CAGR Pendapatan 3T)	-7.0%rata-rata 5T ≈11.7%	≈11.7%	·	·
Revenue CAGR 5Y (CAGR Pendapatan 5T)	-2.0%	·	·	·

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik	CRBU	rata-rata 5T	Median Rekan	Kesimpulan
EPS (Diluted)	$-1.59rata-rata 5T ≈$-1.67	≈$-1.67	·	·
Revenue / Share (Pendapatan / Saham)	$0.12rata-rata 5T ≈$0.23	≈$0.23	·	·
Cash Flow / Share (Arus Kas / Saham)	$-1.19rata-rata 5T ≈$-1.37	≈$-1.37	·	·
Cash / Share (Kas / Saham)	$0.13rata-rata 5T ≈$1.17	≈$1.17	·	·

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik	CRBU	rata-rata 5T	Median Rekan	Kesimpulan
Asset Turnover (Perputaran Aset)	0.0rata-rata 5T ≈0.0	≈0.0	0.0	Tingkat teratas
Receivables Turnover (Perputaran Piutang)	66.8rata-rata 5T ≈69.5	≈69.5	4.7	Tingkat teratas
Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.)	≈$115.0K	·	·	·

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14

Kejutan Rata-rata 5.8%

Laporan Berikutnya Nov 09, 2026

Periode	Laporan	EPS Aktual	EPS Estimasi	Kejutan
30 Juni 2026	Agu 13, 2026	$-0.24	$-0.32	25.7%
31 Maret 2026		$-0.26	$-0.32	19.8%
31 Des. 2025		$-0.28	$-0.32	11.4%
30 Sep. 2025		$-0.30	$-0.37	18.4%
30 Juni 2025		$-0.58	$-0.40	-45.1%
31 Maret 2025		$-0.43	$-0.45	4.7%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15

Laporan Laba Rugi 15

Metrik	2025	2024	2023	2022	2021	2020
Revenue	$11M	$10M	$34M	$14M	$10M	$12M
R&D Expense	$109M	$130M	$112M	$82M	$52M	$34M
SG&A Expense	$38M	$46M	$38M	$38M	$24M	$14M
Operating Expenses	$160M	$177M	$151M	$120M	$77M	$48M
Operating Income	$-148M	$-167M	$-116M	$-106M	$-67M	$-36M
Interest Expense	·	·	·	·	$8.0K	$20.0K
Other Non-op	$-331.0K	$18M	$14M	$7M	$377.0K	$-3.0K
Pretax Income	$-149M	$-149M	$-102M	$-99M	$-67M	$-36M
Income Tax	$-550.0K	$-9.0K	$193.0K	$70.0K	$321.0K	$-2M
Net Income	$-148M	$-149M	$-102M	$-99M	$-67M	$-34M
EPS (Basic)	$-1.59	$-1.65	$-1.38	$-1.64	$-2.11	·
EPS (Diluted)	$-1.59	$-1.65	$-1.38	$-1.64	$-2.11	·
Shares (Basic)	93,389,283	90,317,925	73,807,597	60,801,133	31,663,243	·
Shares (Diluted)	93,389,283	90,317,925	73,807,597	60,801,133	31,663,243	·
EBITDA	$-145M	$-163M	$-113M	$-105M	$-66M	·

Neraca 23

Metrik	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$12M	$16M	$51M	$58M	$240M	$16M
Short-term Investments	·	·	·	·	$135M	$0
Receivables	$69.0K	$265.0K	$148.0K	$202.0K	$1M	$150.0K
Prepaid Expense	$3M	$7M	$6M	$8M	$7M	$3M
Current Assets	$145M	$219M	$339M	$260M	$391M	$24M
PP&E (Net)	$7M	$19M	$18M	$11M	$5M	$4M
PP&E (Gross)	$20M	$32M	$27M	$16M	$9M	$7M
Accum. Depreciation	$14M	$13M	$9M	$6M	$4M	$3M
Other Non-current Assets	$2M	$6M	$2M	$2M	$975.0K	$612.0K
Total Assets	$175M	$313M	$432M	$374M	$442M	$36M
Accounts Payable	$6M	$2M	$3M	$1M	$4M	$3M
Accrued Liabilities	$17M	$24M	$21M	$16M	$13M	$9M
Current Liabilities	$25M	$31M	$28M	$28M	$26M	$12M
Capital Leases	$26M	$25M	$26M	$27M	$0	·
Deferred Tax	$0	$548.0K	$557.0K	$381.0K	$476.0K	$155.0K
Total Liabilities	$53M	$60M	$64M	$73M	$55M	$18M
Common Stock	$9.0K	$9.0K	$8.0K	$6.0K	$6.0K	$1.0K
Paid-in Capital	$719M	$701M	$668M	$500M	$486M	$7M
Retained Earnings	$-597M	$-448M	$-299M	$-197M	$-98M	$-31M
AOCI	$103.0K	$255.0K	$30.0K	$-2M	$-135.0K	$0
Stockholders' Equity	$122M	$253M	$368M	$301M	$388M	$-23M
Liabilities + Equity	$175M	$313M	$432M	$374M	$442M	$36M
Shares Outstanding	95,143,690	92,378,577	88,448,948	61,029,184	60,263,158	9,710,829

Arus Kas 14

Metrik	2025	2024	2023	2022	2021	2020
D&A	$4M	$4M	$4M	$2M	$984.0K	$900.0K
Stock-based Comp	$13M	$17M	$14M	$12M	$3M	$1M
Deferred Tax	$-551.0K	$-10.0K	$178.0K	$-95.0K	$320.0K	$-919.0K
Other Non-cash	$21M	$-10M	$-9M	$-5M	$30M	·
Operating Cash Flow	$-111M	$-138M	$-93M	$-91M	$-33M	$-33M
CapEx	$1M	$5M	$12M	$6M	$2M	$317.0K
Investing Cash Flow	$102M	$87M	$-68M	$-93M	$-176M	$6M
Stock Issued	$4M	$15M	$1M	$0	·	·
Net Stock Activity	$4M	$15M	$1M	·	·	·
Financing Cash Flow	$5M	$17M	$154M	$2M	$433M	$2M
Net Change in Cash	$-4M	$-35M	$-7M	$-182M	$225M	$-25M
Taxes Paid	·	$0	$170.0K	$0	$11.0K	$21.0K
Free Cash Flow	$-112M	$-143M	$-105M	$-97M	$-35M	·
Levered FCF	·	·	·	·	$-35M	·

Profitabilitas 7

Metrik	2025	2024	2023	2022	2021	2020
Operating Margin	-1329.4%	-1667.2%	-336.6%	-768.2%	-697.8%	·
Net Margin	-1327.4%	-1491.9%	-296.1%	-717.8%	-697.3%	·
Pretax Margin	-1332.3%	-1492.0%	-295.5%	-717.3%	-693.9%	·
EBITDA Margin	-1296.7%	-1627.9%	-326.4%	-756.5%	-687.6%	·
ROA	-60.6%	-40.0%	-25.3%	-24.4%	-28.0%	·
ROE	-102.8%	-55.8%	-26.6%	-31.8%	-16.9%	·
ROIC	-121.0%	-65.9%	-31.6%	-35.4%	-17.3%	·

Likuiditas & Solvabilitas 3

Metrik	2025	2024	2023	2022	2021	2020
Current Ratio	5.7	7.2	12.0	9.3	15.1	·
Quick Ratio	0.5	0.5	1.8	2.1	9.4	·
Interest Coverage	·	·	·	·	-8372.4	·

Efisiensi 2

Metrik	Tren	2025	2024	2023	2022	2021	2020
Asset Turnover		0.0	0.0	0.1	0.0	0.0	·
Receivables Turnover		66.8	48.4	197.0	20.4	14.7	·

Per Saham 5

Metrik	2025	2024	2023	2022	2021	2020
Book Value / Share	$1.28	$2.74	$4.17	$4.93	$6.44	·
Revenue / Share	$0.12	$0.11	$0.47	$0.23	·	·
Cash Flow / Share	$-1.19	$-1.53	$-1.26	$-1.50	·	·
Cash / Share	$0.13	$0.18	$0.58	$0.96	$3.99	·
EPS (TTM)	$-1.59	$-1.65	$-1.38	$-1.64	$-2.11	·

Tingkat Pertumbuhan 3

Metrik	2025	2024	2023	2022	2021	2020
Revenue YoY	11.7%	-71.0%	148.9%	44.3%	-22.4%	·
Revenue CAGR 3Y	-7.0%	1.4%	40.8%	·	·	·
Revenue CAGR 5Y	-2.0%	·	·	·	·	·

Valuasi (TTM) 10

Metrik	2025	2024	2023	2022	2021	2020
Revenue TTM	$11M	$10M	$34M	$14M	$10M	·
Net Income TTM	$-148M	$-149M	$-102M	$-99M	$-67M	·
Market Cap	$151M	$147M	$507M	$383M	$909M	·
P/E	-1.0	-1.0	-4.2	-3.8	-7.2	·
P/S	13.6	14.7	14.7	27.7	94.7	·
P/B	1.2	0.6	1.4	1.3	2.3	·
P / Tangible Book	1.2	0.6	1.4	1.3	2.3	·
P / Cash Flow	-1.4	-1.1	-5.4	-4.2	-28.0	·
P / FCF	-1.3	-1.0	-4.8	-3.9	-26.3	·
Earnings Yield	-100.0%	-103.8%	-24.1%	-26.1%	-14.0%	·

Laporan Laba Rugi 13

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$1M	$2M	$4M	$2M	$3M	$2M	$2M	$2M	$3M	$2M	$4M	$24M	$4M	$4M	$4M	$3M
R&D Expense	$19M	$21M	$24M	$22M	$28M	$36M	$30M	$30M	$35M	$34M	$31M	$29M	$27M	$26M	$26M	$20M
SG&A Expense	$8M	$8M	$9M	$9M	$10M	$10M	$10M	$10M	$11M	$15M	$10M	$10M	$10M	$9M	$9M	$10M
Operating Expenses	$27M	$29M	$32M	$32M	$50M	$45M	$41M	$40M	$47M	$48M	$41M	$38M	$37M	$35M	$34M	$30M
Operating Income	$-25M	$-26M	$-28M	$-29M	$-48M	$-43M	$-39M	$-38M	$-44M	$-46M	$-37M	$-15M	$-33M	$-31M	$-31M	$-27M
Other Non-op	$1M	$1M	$1M	$2M	$-7M	$3M	$3M	$4M	$6M	$5M	$3M	$5M	$3M	$3M	$4M	$-110.0K
Income Tax	·	$0	$-550.0K	$0	·	$0	$-9.0K	$0	$0	$0	$193.0K	$0	$0	$0	$70.0K	$0
Net Income	$-24M	$-25M	$-26M	$-28M	$-54M	$-40M	$-35M	$-35M	$-38M	$-41M	$-35M	$-10M	$-30M	$-28M	$-27M	$-27M
EPS (Basic)	$-0.24	$-0.26	$-0.28	$-0.30	$-0.58	$-0.43	$-0.39	$-0.38	$-0.42	$-0.46	$-0.32	$-0.12	$-0.48	$-0.46	$-0.44	$-0.44
EPS (Diluted)	$-0.24	$-0.26	$-0.28	$-0.30	$-0.58	$-0.43	$-0.39	$-0.38	$-0.42	$-0.46	$-0.32	$-0.12	$-0.48	$-0.46	$-0.44	$-0.44
Shares (Basic)	100,985,698	95,861,716	·	93,293,099	93,028,698	92,679,493	·	90,455,900	90,340,932	89,302,937	·	83,783,992	61,417,934	61,186,514	·	60,886,921
Shares (Diluted)	100,985,698	95,861,716	·	93,293,099	93,028,698	92,679,493	·	90,455,900	90,340,932	89,302,937	·	83,783,992	61,417,934	61,186,514	·	60,886,921
EBITDA	$-25M	$-26M	·	$-29M	$-48M	$-42M	·	$-38M	$-44M	$-45M	·	$-15M	·	·	·	$-27M

Neraca 22

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$26M	$12M	$12M	$11M	$25M	$29M	$16M	$32M	$38M	$49M	$51M	$104M	$66M	$53M	$58M	$82M
Receivables	$203.0K	$227.0K	$69.0K	$242.0K	$71.0K	$88.0K	$265.0K	$184.0K	$215.0K	$917.0K	$148.0K	$1M	$766.0K	$2M	$202.0K	$397.0K
Prepaid Expense	$2M	$2M	$3M	$5M	$6M	$6M	$7M	$7M	$6M	$7M	$6M	$7M	$6M	$6M	$8M	$9M
Current Assets	$117M	$122M	$145M	$156M	$193M	$217M	$219M	$237M	$271M	$305M	$339M	$351M	$269M	$239M	$260M	$307M
PP&E (Net)	$5M	$6M	$7M	$8M	$8M	$19M	$19M	$20M	$20M	$19M	$18M	$17M	$15M	$13M	$11M	$9M
PP&E (Gross)	$20M	$20M	$20M	$20M	$20M	$33M	$32M	$31M	$31M	$29M	$27M	$25M	$22M	$19M	$16M	$14M
Accum. Depreciation	$15M	$14M	$14M	$13M	$12M	$14M	$13M	$12M	$11M	$10M	$9M	$8M	$7M	$6M	$6M	$5M
Other Non-current Assets	$2M	$2M	$2M	$4M	$4M	$5M	$6M	$5M	$2M	$2M	$2M	$2M	$1M	$1M	$2M	$1M
Total Assets	$143M	$149M	$175M	$195M	$221M	$274M	$313M	$344M	$373M	$407M	$432M	$458M	$350M	$347M	$374M	$399M
Accounts Payable	$3M	$4M	$6M	$4M	$3M	$4M	$2M	$3M	$3M	$6M	$3M	$2M	$4M	$3M	$1M	$1M
Accrued Liabilities	$13M	$14M	$17M	$19M	$21M	$20M	$24M	$25M	$24M	$19M	$21M	$18M	$16M	$13M	$16M	$15M
Current Liabilities	$18M	$20M	$25M	$28M	$29M	$28M	$31M	$32M	$31M	$29M	$28M	$25M	$34M	$27M	$28M	$29M
Capital Leases	$25M	$26M	$26M	$23M	$24M	$24M	$25M	$25M	$26M	$26M	$26M	$26M	$26M	$26M	$27M	$27M
Deferred Tax	·	·	$0	$548.0K	$548.0K	$548.0K	$548.0K	$557.0K	$557.0K	$556.0K	$557.0K	$381.0K	$380.0K	$382.0K	$381.0K	$475.0K
Total Liabilities	$45M	$47M	$53M	$53M	$55M	$56M	$60M	$63M	$62M	$64M	$64M	$59M	$80M	$69M	$73M	$75M
Common Stock	$11.0K	$10.0K	$9.0K	$9.0K	$9.0K	$9.0K	$9.0K	$9.0K	$9.0K	$9.0K	$8.0K	$8.0K	$6.0K	$6.0K	$6.0K	$6.0K
Paid-in Capital	$744M	$724M	$719M	$712M	$709M	$705M	$701M	$693M	$689M	$684M	$668M	$664M	$525M	$504M	$500M	$496M
Retained Earnings	$-646M	$-622M	$-597M	$-570M	$-542M	$-488M	$-448M	$-413M	$-378M	$-341M	$-299M	$-265M	$-255M	$-225M	$-197M	$-170M
AOCI	$-71.0K	$-23.0K	$103.0K	$93.0K	$40.0K	$167.0K	$255.0K	$789.0K	$-319.0K	$-322.0K	$30.0K	$-981.0K	$-1M	$-730.0K	$-2M	$-2M
Stockholders' Equity	$98M	$102M	$122M	$142M	$166M	$217M	$253M	$281M	$310M	$343M	$368M	$398M	$269M	$278M	$301M	$324M
Liabilities + Equity	$143M	$149M	$175M	$195M	$221M	$274M	$313M	$344M	$373M	$407M	$432M	$458M	$350M	$347M	$374M	$399M
Shares Outstanding	105,995,653	96,951,234	95,143,690	93,468,038	93,123,239	93,004,602	92,378,577	90,552,687	90,362,771	90,314,501	88,448,948	88,430,609	66,100,039	61,323,523	61,029,184	60,986,936

Arus Kas 13

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$625.0K	$649.0K	$682.0K	$631.0K	$1M	$1M	$1M	$1M	$856.0K	$710.0K	$740.0K	$2M	$617.0K	$589.0K	$506.0K	$450.0K
Stock-based Comp	$2M	$2M	$3M	$3M	$3M	$4M	$4M	$4M	$5M	$4M	$4M	$3M	$4M	$3M	$3M	$3M
Restructuring	·	·	·	·	·	·	·	$600.0K	·	·	·	·	·	·	·	·
Other Non-cash	·	$-5M	·	·	·	$-2M	·	·	·	$-667.0K	·	·	·	·	·	·
Operating Cash Flow	$-23M	$-27M	$-21M	$-25M	$-28M	$-37M	$-35M	$-33M	$-33M	$-37M	$-21M	$-29M	$-15M	$-28M	$-25M	$-22M
CapEx	$1.0K	$72.0K	$-216.0K	$115.0K	$418.0K	$1M	$518.0K	$673.0K	$2M	$1M	$2M	$5M	$3M	$2M	$2M	$1M
Investing Cash Flow	$19M	$24M	$18M	$11M	$24M	$49M	$16M	$27M	$21M	$23M	$-31M	$-68M	$11M	$21M	$1M	$-8M
Stock Issued	$18M	$2M	$4M	$0	$0	$0	$4M	$0	$0	$11M	$0	$-1.0K	$-115.0K	$1M	$0	$0
Net Stock Activity	·	$2M	·	·	·	$0	·	·	·	$11M	·	·	·	·	·	·
Financing Cash Flow	$18M	$3M	$4M	$277.0K	$6.0K	$468.0K	$4M	$244.0K	$132.0K	$12M	$-43.0K	$135M	$18M	$2M	$127.0K	$654.0K
Net Change in Cash	$14M	$-303.0K	$1M	$-14M	$-4M	$13M	$-16M	$-6M	$-12M	$-2M	$-53M	$38M	$13M	$-6M	$-24M	$-30M
Taxes Paid	·	·	·	·	·	·	·	$0	·	·	$0	$0	·	·	$0	$0
Free Cash Flow	·	$-27M	·	·	·	$-38M	·	·	·	$-39M	·	·	·	·	·	·

Profitabilitas 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-1690.4%	-1096.4%	·	-1337.6%	-1784.0%	-1823.8%	·	-1889.2%	-1255.8%	-1893.9%	·	-61.8%	·	·	·	-803.4%
Net Margin	-1619.9%	-1046.5%	·	-1253.3%	-2028.4%	-1699.6%	·	-1713.6%	-1088.2%	-1697.6%	·	-42.3%	·	·	·	-806.8%
EBITDA Margin	-1690.4%	-1069.3%	·	-1337.6%	-1784.0%	-1774.2%	·	-1889.2%	-1255.8%	-1864.6%	·	-61.8%	·	·	·	-803.4%
ROA	-13.4%	-11.9%	·	-10.2%	-18.2%	-11.8%	·	-8.6%	-10.4%	-10.9%	·	-2.3%	·	·	·	-6.2%
ROE	-18.4%	-15.7%	·	-13.0%	-22.7%	-14.3%	·	-10.2%	-13.0%	-13.3%	·	-2.8%	·	·	·	-7.3%

Likuiditas & Solvabilitas 2

Metrik	Tren	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		6.5	6.2	·	5.5	6.7	7.6	·	7.4	8.8	10.5	·	14.3	·	·	·	10.7
Quick Ratio		1.5	0.6	·	0.4	0.9	1.0	·	1.0	1.2	1.7	·	4.3	·	·	·	2.9

Efisiensi 2

Metrik	Tren	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.1	·	·	·	0.0
Receivables Turnover		10.9	15.2	·	10.3	18.7	4.7	·	3.1	7.1	2.0	·	30.9	·	·	·	6.8

Per Saham 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.93	$1.05	·	$1.52	$1.78	$2.34	·	$3.11	$3.44	$3.80	·	$4.50	·	·	·	$5.31
Revenue / Share	$0.01	$0.03	·	$0.02	$0.03	$0.03	·	$0.02	$0.04	$0.03	·	$0.28	·	·	·	$0.05
Cash Flow / Share	·	$-0.28	·	·	·	$-0.40	·	·	·	$-0.42	·	·	·	·	·	·
Cash / Share	$0.25	$0.12	·	$0.12	$0.27	$0.32	·	$0.35	$0.42	$0.55	·	$1.18	·	·	·	$1.35
EPS (TTM)	$-1.08	$-1.42	·	$-1.70	$-1.78	$-1.62	·	$-1.58	$-1.32	$-1.38	·	$-1.50	$-1.82	$-1.66	·	$-1.11

Valuasi (TTM) 9

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$10M	$11M	·	$9M	$9M	$10M	·	$11M	$33M	$33M	·	$35M	$15M	$14M	·	$13M
Net Income TTM	$-103M	$-133M	·	$-157M	$-164M	$-148M	·	$-148M	$-123M	$-115M	·	$-95M	$-111M	$-100M	·	$-91M
Market Cap	$187M	$184M	·	$218M	$117M	$85M	·	$177M	$148M	$464M	·	$423M	·	·	·	$643M
P/E	-1.6	-1.3	·	-1.4	-0.7	-0.6	·	-1.2	-1.2	-3.7	·	-3.2	-2.3	-3.2	·	-9.5
P/S	18.6	16.4	·	23.4	12.9	8.6	·	15.5	4.5	13.9	·	12.2	·	·	·	50.6
P/B	1.9	1.8	·	1.5	0.7	0.4	·	0.6	0.5	1.4	·	1.1	·	·	·	2.0
P / Tangible Book	1.9	1.8	·	1.5	0.7	0.4	·	0.6	0.5	1.4	·	1.1	1.0	1.2	·	2.0
P / Cash Flow	·	-6.8	·	·	·	-2.3	·	·	·	-12.5	·	·	·	·	·	·
Earnings Yield	-61.4%	-74.7%	·	-73.0%	-141.3%	-177.4%	·	-80.6%	-80.5%	-26.9%	·	-31.4%	-42.8%	-31.3%	·	-10.5%

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Pendapatan	$11M	$10M	$34M	$14M	$10M
Margin Operasi %	-1329.4%	-1667.2%	-336.6%	-768.2%	-697.8%
Laba Bersih	$-148M	$-149M	$-102M	$-99M	$-67M
EPS Dilusian	$-1.59	$-1.65	$-1.38	$-1.64	$-2.11

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rasio Lancar	5.7	7.2	12.0	9.3	15.1
Rasio Cepat	0.5	0.5	1.8	2.1	9.4

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Arus Kas Bebas	$-112M	$-143M	$-105M	$-97M	$-35M

Pemilik institusional (13F) 148 pengaju · $89.6M total · Per tanggal 30 Juni 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 148

Nilai yang dipegang $89.6M

Posisi baru 26

Posisi yang keluar 22

Aktivitas institusional — Q2 2026 vs kuartal sebelumnya

Posisi baru	Posisi yang keluar	Meningkat	Menurun	Perubahan bersih saham
26 (-4 vs Kuartal sebelumnya)	22 (+11 vs Kuartal sebelumnya)	45 (+14 vs Kuartal sebelumnya)	28 (-10 vs Kuartal sebelumnya)	+10.5M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi	Nilai	Saham	% dari 13F yang dilacak	Tipe
BlackRock, Inc.	$13.755.883	7.815.843	15,36%	Saham
Pfizer Inc	$7.879.924	4.690.431	8,80%	Saham
VANGUARD CAPITAL MANAGEMENT LLC	$7.407.080	4.208.568	8,27%	Saham
VANGUARD GROUP INC	$6.843.676	4.304.198	7,64%	Saham
MACKENZIE FINANCIAL CORP	$6.425.401	3.650.796	7,17%	Saham
RENAISSANCE TECHNOLOGIES LLC	$4.881.439	2.773.545	5,45%	Saham
Kynam Capital Management, LP	$4.405.812	2.503.302	4,92%	Saham
GEODE CAPITAL MANAGEMENT, LLC	$4.180.624	2.374.894	4,67%	Saham
STATE STREET CORP	$2.873.929	1.632.914	3,21%	Saham
BANK OF AMERICA CORP /DE/	$2.483.287	1.410.958	2,77%	Saham
TWO SIGMA INVESTMENTS, LP	$1.841.451	1.046.279	2,06%	Saham
TWO SIGMA ADVISERS, LP	$1.773.963	1.115.700	1,98%	Saham
DIMENSIONAL FUND ADVISORS LP	$1.716.629	975.327	1,92%	Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1.365.424	775.809	1,52%	Saham
FMR LLC	$1.279.722	727.115	1,43%	Saham
NORTHERN TRUST CORP	$1.254.819	712.965	1,40%	Saham
MAVERICK CAPITAL LTD	$1.148.474	652.542	1,28%	Saham
VANGUARD PORTFOLIO MANAGEMENT LLC	$1.080.290	613.801	1,21%	Saham
VANGUARD FIDUCIARY TRUST CO	$1.067.243	606.388	1,19%	Saham
Qube Research & Technologies Ltd	$960.529	545.755	1,07%	Saham
UBS Group AG	$910.573	517.371	1,02%	Saham
72 Investment Holdings, LLC	$834.358	474.067	0,93%	Saham
JACOBS LEVY EQUITY MANAGEMENT, INC	$723.323	410.979	0,81%	Saham
MARSHALL WACE, LLP	$661.205	375.686	0,74%	Saham
Green Alpha Advisors, LLC	$641.210	364.324	0,72%	Saham
PFM Health Sciences, LP	$624.249	354.687	0,70%	Saham
GOLDMAN SACHS GROUP INC	$568.260	322.875	0,63%	Saham
Invesco Ltd.	$529.966	301.117	0,59%	Saham
WELLS FARGO & COMPANY/MN	$525.035	298.315	0,59%	Saham
XTX Topco Ltd	$473.716	269.157	0,53%	Saham
Bruce & Co., Inc.	$440.000	250.000	0,49%	Saham
Man Group plc	$422.516	240.066	0,47%	Saham
Bank of New York Mellon Corp	$391.706	222.560	0,44%	Saham
MILESTONE ASSET MANAGEMENT, LLC	$352.150	200.085	0,39%	Saham
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	$305.140	173.375	0,34%	Saham
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$291.129	165.414	0,33%	Saham
Susquehanna Portfolio Strategies, LLC	$279.131	158.597	0,31%	Saham
Graham Capital Management, L.P.	$274.409	155.914	0,31%	Saham
AMERICAN CENTURY COMPANIES INC	$247.421	140.580	0,28%	Saham
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$232.320	132.000	0,26%	Saham
Nuveen, LLC	$217.388	123.516	0,24%	Saham
CITADEL ADVISORS LLC	$217.008	123.300	0,24%	Opsi beli
Cubist Systematic Strategies, LLC	$216.135	92.762	0,24%	Saham
LPL Financial LLC	$216.082	122.774	0,24%	Saham
MORGAN STANLEY	$213.523	121.320	0,24%	Saham
NANO CAP NEW MILLENNIUM GROWTH FUND L P	$206.800	117.500	0,23%	Saham
DEUTSCHE BANK AG\	$157.652	89.575	0,18%	Saham
Quadrature Capital Ltd	$156.603	88.979	0,17%	Saham
CANADA PENSION PLAN INVESTMENT BOARD	$142.736	81.100	0,16%	Saham
Keystone Financial Group	$142.252	80.825	0,16%	Saham

Tampilkan semua 148 pemilik institusional →

Aktivis & pemilik 5%+ 1 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju	Diajukan	Kepemilikan	Status	Tujuan	Pengajuan
The City Canyon Family Trust dated May 31, 2021, Rachel E. Haurwitz, Felix Adler ×3 pengajuan	25 April 2025	5,00%	Pengajuan awal	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Orang dalam perusahaan 18 orang dalam · 9 pejabat · 7 direktur

19

Orang Dalam	Peran	Aktivitas terakhir	Saham dimiliki	Jual 12m	Bersih 12m
Rachel E. Haurwitz	President and CEO	20 Feb. 2026 A	447.150	0	$0
Sriram Ryali	Chief Financial Officer	20 Feb. 2026 A	72.360	0	$0
Jason O'Byrne	Chief Financial Officer	20 Feb. 2024 A	59.224	0	$0
Timothy P Kelly	Chief Technology Officer	25 Feb. 2026 S	73.125	2	$-18.188
Tina M. Albertson	Chief Medical Officer	20 Feb. 2026 A	68.523	1	$-2.089
Ruhi Ahmad Khan	Chief Business Officer	20 Feb. 2026 A	104.998	1	$-13.598
Steven Kanner	Chief Scientific Officer	20 Feb. 2025 A	431.556	0	$0
Ryan Fischesser	VP of Finance and Controller	20 Nov. 2024 A	118.854	0	$0
Syed Ali-Aamir Rizvi	Chief Medical Officer	21 Feb. 2023 A	59.373	0	$0
Dara Richardson-Heron	Direktur	20 Feb. 2026 A	·	0	$0
Ran Zheng	Direktur	20 Feb. 2026 A	·	0	$0
Nancy Whiting	Direktur	20 Feb. 2026 A	·	0	$0
David Lee Johnson	Direktur	20 Feb. 2026 A	·	0	$0
Natalie Sacks	Direktur	20 Feb. 2026 A	·	0	$0
Scott Braunstein	Direktur	20 Feb. 2026 A	·	0	$0
Barbara G Mcclung	·	20 Feb. 2026 A	481.564	1	$-13.598
Andrew Guggenhime	·	20 Feb. 2026 A	·	0	$0
FMR LLC	·	27 Juli 2021 C	1.464.775	0	$0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 15 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana	Bobot	Unit	Per tanggal	Sumber
OMFS · Invesco Exchange-Traded Self-Indexe…	0,08%	164.575 SH	2 Okt. 2026	Harian
IWC · iShares Trust	0,03%	319.257 SH	11 Sep. 2026	Harian
VTWV · VANGUARD SCOTTSDALE FUNDS	0,01%	79.869 SH	19 Agu 2026	Harian
IBB · iShares Trust	0,01%	670.052 SH	11 Sep. 2026	Harian
IBBQ · Invesco Exchange-Traded Fund Trust …	0,01%	6.958 SH	2 Okt. 2026	Harian
PRFZ · Invesco Exchange-Traded Fund Trust	0,01%	131.852 SH	2 Okt. 2026	Harian
RSSL · Global X Funds	0,00%	43.883 NS	31 Juli 2026	N-PORT
IWM · iShares Trust	0,00%	2.250.647 SH	11 Sep. 2026	Harian
DFAS · Dimensional ETF Trust	0,00%	255.338 NS	31 Juli 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	74.931 NS	31 Juli 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	1.113.215 SH	19 Agu 2026	Harian
VTI · VANGUARD INDEX FUNDS	0,00%	3.013.973 SH	19 Agu 2026	Harian
VTWO · VANGUARD SCOTTSDALE FUNDS	0,00%	524.917 SH	19 Agu 2026	Harian
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	9.015 SH	19 Agu 2026	Harian
IWN · iShares Trust	·	875.712 SH	11 Sep. 2026	Harian

CRBU Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21

peringkat · 13 analis BELI

Target median $10.00 +719,7%

5 38,5% Beli Kuat

7 53,8% Beli

1 7,7% Tahan

0 0,0% Jual

0 0,0% Jual Kuat

Target Harga 12 Bulan

7 analis · 2026-10-02

Target rata-rata $11.86 +871,9%

← Di bawah semua target Harga saat ini $1.22

Rendah$4.00 Rata-rata$11.86 Tinggi$32.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker	Kapitalisasi Pasar	P/E	Pendapatan YoY	Margin Bersih	ROE	Margin Kotor
CRBU	$151M	-1.0	11.7%	-1327.4%	-102.8%	·
KRRO	$75M	-0.6	181.5%	-1834.5%	-140.8%	·
OTLK	$57M	-0.6	·	-4416.2%	193.1%	4.0%
FHTX	$306M	-4.6	36.8%	-240.3%	80.2%	·
PMVP	$67M	-0.8	-40.5%	-1226.8%	-63.4%	·
RNA	$10.91B	-14.5	72.1%	-3650.4%	-47.5%	·
SPRB	$120M	-1.7	-51.3%	·	-139.9%	·
TNYA	$154M	-1.2	·	·	-81.2%	·
CBUS	·	-0.6	-14.6%	-3492.3%	-223.0%	·
INO	$120M	-1.0	-70.0%	-130000.0%	-322.8%	·

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

CRBU Caribou Biosciences, Inc. - Common Stock

CRBU Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

CRBU Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

Pemilik institusional (13F) 148 pengaju · $89.6M total · Per tanggal 30 Juni 2026

Aktivis & pemilik 5%+ 1 saham

Orang dalam perusahaan 18 orang dalam · 9 pejabat · 7 direktur

Kepemilikan ETF Dimiliki oleh 15 ETF

CRBU Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

Target Harga 12 Bulan

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap